Sponsor study identifier
observational
10,000
1 country
1
Study Start
August 2015
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This is a prospective, multi-center, hospital-based observational study. The aim of the study is to evaluate the prevalence of chronic kidney disease in patients with stable coronar heart disease.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 23, 2015
Actual (reported)July 27, 2015
Actual (reported)August 2015
Date type not reportedThis date has not been verified as actual or estimated.
March 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
prevalence of chronic kidney disease in patients with stable coronary heart disease
After recruitment, urinalysis, urine albumin/creatinine ratio(ACR), and serum creatitine will be tested. Chronic kidney disease is defined as ≥1 of the following abnormalities: 1)estimated GFR\<60ml/min per1.73m2. The eGFR is estimated using the CKD-EPI equation ; 2) Presence of proteinuria. Proteinuria is defined as urine ACR \>30mg/g, or urinalysis showing positive proteinuria.
1 year
the awareness rate of chronic kidney disease in patients with stable coronary heart disease
1 year
factors associated with chronic kidney disease in patients with stable coronary heart disease
1 year
the association between CKD and cardiovascular events during one-year's follow-up
2 year
100 eligible sites over the country will participate. Each site will recruit patients who fit the inclusion standard in chronological order
Peking University First hospital
Beijing, Beijing Municipality, 100034, China
Yong Huo, MD
Peking University First Hospital
First Submitted
July 23, 2015
First Posted
July 27, 2015
Study Start
August 2015
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2017
Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease
Association Between Mitochondrial DNA Content and Risk of Coronary Heart Disease
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
June 21, 2016
Record last verified: 2016-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: